Disclosure of interest: Maria-Carmen Sobrino-Sanchez: nothing to disclose, Trinidad Bruna Melo: nothing to disclose, Maria-Arantzazu Ruescas-Nicolau: nothing to disclose, M.Luz Snchez-Snchez: nothing to disclose, Carla Fleque-Miravet: nothing to disclose, Patricia Gil-Gas: nothing to disclose, Josefa Segura-Navarro: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2212 - ESOC25-648 PREDICTION OF FUNCTIONAL OUTCOME IN ISCHEMIC STROKE PATIENTS UNDERGOING MECHANICAL THROMBECTOMY USING A LOGISTIC REGRESSION MODEL Diana Luca Tarruella Hernndez 1,2 , Antonio Garca Molina 3 , lvaro Lucero Garfano 2 , Alicia Aliena-Valero 2 , Manuel Pedrero Prieto 1 , Carlos Benlloch Lpez 1 , Lluis Morales Caba 1 , Gerardo Fortea 1 , Juan Bautista Salom Sanvalero 1,2 , Irene Escudero Martnez 1 , Jose Ignacio Tembl 1 1 Hospital Universitari i Politcnic La Fe, Valencia, Spain, 2 Instituto de Investigacin Sanitaria La Fe, Valencia, Spain, 3 Hospital de Dnia, Alicante, Spain Background and Aims: To develop a predictive model for 90-day functional outcomes in patients undergoing mechanical thrombectomy (MT) based on clinical and demographic variables
Highlights: Made in Japan, FDA-registered in both Japan and the Philippines, produced in ISO/GMP/HALAL-certified facilities
GLP-1s are ideal for people who: Have a BMI of 27+ (with a medical condition) or 30+ Have tried and failed at traditional diet/exercise plans Want a medical, non-surgical approach Are experiencing weight gain due to hormonal shifts, stress, or emotional eating Contraindications include: Personal or family history of medullary thyroid carcinoma (MTC) History of Multiple Endocrine Neoplasia syndrome type 2 (MEN2) History of pancreatitis Pregnancy, breastfeeding or planning to conceive (uncertainty due to limited human studies) Type 1 diabetes (these meds are not approved for this condition) GLP-1 medications are not appropriate for everyone
Additionally, discussing any known allergies or previous reactions to injections with your healthcare provider can help tailor a safer treatment approach for you
Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S
10.1073/pnas.1410104111 Proc
